Alzheimer drug worsens neurological dysfunction in multiple sclerosis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2009
To assess the efficacy of Memantine in improving the cognitive impairment in patients with Multiple Sclerosis (MS)
Epistemonikos ID: e317eabf07f4c1c1f6afae0db2bb5fe791601d0e
First added on: Mar 31, 2022